Inflarx N V Asset Turnover Ratio (IFRX), as of fourth quarter 2025, current and historic results, rankings and more - CSIMarket
CSIMarket Company Name, Ticker, Competitors, else..
 


• Sales per Employee
• Income per Employee
• Inventory Turnover
• Asset Turnover
• Receivables Turnover
Inflarx N V  (NASDAQ: IFRX)
 

Inflarx N V Asset Turnover Ratio

Quarterly Results, Trends, Rankings, Statistics

According to the latest Balance sheet Dec 31 2025, Inflarx N V has not recorded any assets.
Visit Inflarx N V Balance sheet

Within sector 250 more businesses have achieved higher asset turnover ratio. While ranking the asset turnover ratio, among all other companies, it is fair to say, that the company's position has deteriorated in the fourth quarter 2025 compared to the preceding quarter from to 4722.

Asset Turnover Ratio Definition


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

IFRX Asset Turnover Ratio (Dec 31 2025)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter		 (Dec 31 2023)
IV. Quarter
Y / Y Asset Change -50.86 % -50.86 % -50.86 % -50.86 % 7.25 %
Y / Y Revenue Change -53.51 % - - - -
Asset Turnover Ratio (TTM) 0 - 0 - 0
IFRX's Total Ranking # 4722 # # # #
Seq. Asset Change 0 % 0 % 0 % -50.86 % 0 %
Seq. Revenue Change - - - - -



Asset Turnover Ratio Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 251
Healthcare Sector # 662
Overall Market # 4722

Asset Turnover Ratio Statistics
High Average Low
0 0 0
(Dec 31 2025)   (Dec 31 2023)




IFRX Company Profile • Back to IFRX Efficiency Comparisons • Compare IFRX Asset Turnover Ratio to its Competitors



Companies with similar Asset Turnover Ratio for the quarter ending Dec 31 2025, within Healthcare Sector Asset Turnover Ratio Revenues for 12 Months ending Dec 31 2025 Assets at quarter ending Dec 31 2025
Silence Therapeutics Plc 0.00 $ 0.559  Millions$ 198.616  Millions
Roivant Sciences Ltd 0.00 $ 13.310  Millions$ 5,242.270  Millions
Prokidney Corp 0.00 $ 0.893  Millions$ 366.344  Millions
Purple Biotech Ltd 0.00 $ 0.039  Millions$ 17.572  Millions
Hcw Biologics Inc 0.00 $ 0.054  Millions$ 26.290  Millions
Pavmed Inc 0.00 $ 0.071  Millions$ 43.399  Millions
Crispr Therapeutics Ag 0.00 $ 3.510  Millions$ 2,176.591  Millions
Cardio Diagnostics Holdings Inc 0.00 $ 0.015  Millions$ 9.808  Millions
Prf Technologies Ltd 0.00 $ 0.017  Millions$ 11.998  Millions
Virax Biolabs Group Limited 0.00 $ 0.006  Millions$ 6.427  Millions
Sera Prognostics Inc 0.00 $ 0.081  Millions$ 110.017  Millions
Inflarx N V 0.00 $ 0.033  Millions$ 61.842  Millions
Opthea Limited 0.00 $ 0.025  Millions$ 56.799  Millions



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.